Viruses that use caveolae-mediated endocytosis
1. Introduction
1.1. Caveolae structure and morphogenesis
Morphologically described as small “caves” in the plasma membrane, caveolae are highly specialized membrane domains with important roles in cell endocytosis, lipid metabolism, and signaling. Since their discovery sixty years ago [1,2], the functional relevance of caveolae has challenged many scientists, raising numerous debates and controversies. The electron microscopy images of caveolae show a rather cell-type-dependent appearance. In endothelial cells, caveolae opening is more constricted [3], while in epithelial cells they appear open to the extracellular medium and smaller in size [4]. In muscle cells, multiple caveolae units cluster together forming T-like tubules invaginating from sarcolemma [5]. Regardless their shape, caveolae appear as immobile structures, in tight connection with the cortical actin cytoskeleton underlying the plasma membrane. Video microscopy and fluorescence recovery after photobleaching analysis have shown that caveolae detach from the membrane only upon ligand binding and specific signaling [6].
The discovery of caveolins (Cav), the structural proteins enveloping caveolae in a spike-like coat [7] marked a significant breakthrough in understanding the nature and importance of these organelles.
Three members of the Cav family have been described in mammalian cells, to date: Cav-1, -2, -3, which share a significant homology and are conserved throughout evolution [8]. Cav-1 and -2 are relatively ubiquitous, with highest distribution in fibroblasts, adipocytes, endothelial cells, and pneumocytes, being co-expressed in most cells types [9]. Cav-3 is expressed independently of Cav-1 and -2 and is limited to skeletal muscle fibers and cardiac myocytes [10-12]. Over-expression of Cav-1 in caveolae-deficient cells is necessary and apparently sufficient to drive caveolae biogenesis [13]. Moreover, Cav-1 expression is required for the membrane localization and stability of Cav-2. Although unable to drive caveolae biogenesis on its own, Cav-2 may however influence it, at least in several polarized, epithelial cells [14,15]. The capacity to modulate caveolae assembly, shape and size has been shown to depend on Cav-2 phosphorylation status [16]. Similar to Cav-1, Cav-3 protein is sufficient to drive formation of caveolae in muscle cells [17].
Most of the molecular data available on caveolins refer to Cav-1; therefore the following discussion will focus on this protein, as a representative of the caveolin family, which is shown schematically in Fig.1.
Cav-1 is an integral membrane protein of 21kDa with an unusual topology. Both the N- and C-termini are cytoplasmically oriented and connected by a central hydrophobic domain, comprising approximately residues 102-134, inserted into, but not spanning the membrane bilayer, in a hairpin (or U bent, or horseshoe) configuration [18,19]. Interestingly, a peptide corresponding to the last 20 residues of the hydrophilic N-domain, (amino acids 82–101) enriched in aromatic residues, can also bind to membranes independently [20,21]. This so-called caveolin scaffolding domain (CSD) is a highly conserved region responsible for many functions associated with Cav-1.
In silico analysis of the conformation of this hydrophobic domain, showed that mutation of a single residue, Pro (110), changes the stable conformation to a straight hydrophobic helix that would span the membrane. Expression of the Cav-1 P110A mutant in HEK 293 cells followed by confocal immunofluorescence microscopy further confirmed the in silico data and the estimated topology [22].
Very recently, circular dichroism and NMR spectroscopy analysis have shown that the transmembrane domain of Cav-1 is primarily α-helical (57-65%). In addition, the helix–break–helix structure was suggested to be critical for the formation of the intra-membrane horseshoe conformation predicted for the protein. Interestingly, mutations of Ile (109) and Pro (110) to Ala dramatically altered the helix-break-helix structure. Moreover, it was shown that substitution of Pro (110) with any other residue results in disruption of the helix-break-helix structure, confirming the importance of the residue in the stability of the hydrophobic domain [23].
An important structural feature of Cav-1 is represented by its arrangement in high molecular mass oligomers of about 350 kDa, composed of 14-16 individual molecules [24,25]. Oligomerization is initiated in the endoplasmic reticulum (ER), where the Cav-1 monomer is co-translationally inserted into the membrane [19] and is rapidly assembled to form SDS-resistant, 8S complexes considered the building units of caveolae structure [24,25]. Intriguingly, blue native gel analysis evidenced only a few intermediate sized oligomers, suggesting that Cav-1 oligomerization is a highly cooperative process [26]. Oligomerization of the full-length protein requires the presence of the CSD and of the C-terminal domain [27] and appears to be stabilized by the palmitoylation of cysteine residues located at positions 133, 143 and 156 [18,28]. At this stage of their assembly, the complexes appear highly mobile in the ER membrane and rapidly concentrate at the ER exit sites, a process favored by the existence of a di-acidic export sequence located at the N-terminal domain. In the absence of this signal sequence, Cav-1 accumulates in lipid droplets [29,30]. This is an important observation, suggesting that ER exit and lipid droplets localization of caveolin complexes are competing processes, highlighting the role of the di-acidic motif in caveolin trafficking.
Interestingly, co-expression of Cav-1 and -2 results in assembly of mixt 8S complexes, where the Cav-1 to Cav-2 ratio may vary from 2:1 to 4:1 [31]; however, expression of Cav-2 alone does not result in oligomer formation.
The process continues in the trans-Golgi where the oligomers are exported in a COPII-dependent manner and self-associate into a large network of caveolin. However, formation of the 8S complex is not a prerequisite for Golgi transport, as expression of Cav- 2 alone, as well as that of an oligomerization-incompetent variant of Cav-1 does not result in their retention within the ER [32,33].
The Golgi oligomerization step is sensitive to BFA, clearly indicating that formation of large oligomer complexes is dependent on caveolins trafficking to this compartment, probably requiring a specific lipid composition of the membrane. The assembly process continues in a cholesterol-dependent manner, resulting in formation of 70S stable complexes, also evidenced by using a panel of anti-Cav-1 conformational antibodies. These complexes were assumed to correspond to the intact protein scaffold of the caveolae structure [34]. It is interesting that the caveolin assemblies colocalized with medial, rather than trans-Golgi markers, suggesting that, unlike other cargos transported through the secretory pathway, caveolar carrier vesicles are formed in the medial cisternae, being further exported to the plasma membrane in a dynamin-2 independent manner, similar to other raft-associated proteins [34]. This assembly process is schematically shown in Fig.2.
It can be concluded from these observations that the tight regulation of Cav-1 trafficking along the secretory compartments (and the multiple check points) is totally justified by the complexity of the assembly process.
In addition to oligomerization, caveola formation involves association of the complexes with cholesterol-rich lipid-raft domains at plasma membrane. It is estimated that Cav-1 binds to 1–2 cholesterol molecules through the conserved basic and hydrophobic residues of the scaffolding domain [35]; thus, the relative amount of cholesterol concentrated in isolated caveolae can be as high as 20.000 molecules [36]. The relationship between cholesterol and caveolins is very complex. Treatment of cells with cholesterol binding or depleting agents results in caveolae with altered morphology and disrupted protein coat [7]. Moreover, cholesterol regulates Cav-1 expression at both, transcriptional and translational levels, through binding to either two steroid regulatory elements in the Cav-1 promoter, or the protein itself, thus modulating the level of Cav-1 mRNA or the protein stability [37,38].
Caveolae are enriched in glycosphingolipids (like GM1 and GM3) and sphingomyelin, the total lipid density being significantly higher than within the rest of the plasma membrane [36]. This is an important observation implying that certain lipids are recruited in caveolae, possibly to ensure their invagination-competent composition.
Recently, a crucial role in the last steps of caveolae biogenesis has been attributed to PTRF (Polymerase I and transcript release factor), originally described as an RNA Pol I transcription factor (also called Cav-P60 or cavin-1) [39,40]. Interestingly, cavin-1 is able to associate with plasma membrane caveolae but not with caveolins with other intracellular distribution (such as Golgi caveolins) [34]. Cavin-1 is recruited by Cav-1 to plasma membrane caveolar domains, where the two proteins are found to be in close proximity and an approximate ration of 1:1 [39]; however, whether or not they directly interact with each other is still a matter of debate. It was clearly demonstrated that cavins bind to phosphatidylserine and are phosphorylated at multiple sites, suggesting they may act as regulatory proteins of caveolae functions [41].
Based on sequence homology with cavin-1, three other proteins named cavin-2 to 4, sharing similar molecular organization, have been identified as part of the cavin family [42-44]. While cavin-1 expression is strictly associated to that of Cav-1 [39] contributing to the stability of the caveolae unit like a scaffolding protein, cavin-2 promotes recruitment of cavin-1 in caveolae and appears to have a role in the membrane-curvature [45].
The role of cavin-3 and -4 in caveolae biogenesis is less well understood. Cavin-3 was shown to regulate caveolae budding and Cav-1 trafficking, suggesting a function in coupling caveolae to the intracellular transport network [44]. Cavin-4 is co-expressed with Cav-3 in cardiac and muscle tissues where their function appears to be tightly correlated [42].
All members of the cavin family interact in a multimeric complex of about 60-80 cavins, in a Cav-1 independent manner. These complexes were detected both in the cytosol and plasma membrane fractions, suggesting they are the result of a succession of events, starting with cavin association into the cytosol and ending with the recruitment of the multimeric complexes to caveolae, during the final step of their biogenesis [42].
In contrast to caveolins, cavins are peripheral membrane proteins, and bind molecular components of the caveolar domain facing the cytosol. Given the high affinity of cavins for phosphatidylserine and the rapid dissociation from caveolae in the presence of nonionic detergents, it was suggested that binding to the lipid membrane, rather than to the protein scaffold, was highly probable.
The identification of cavins in caveolae opened new perspectives in understanding the complexity of caveolar structure. Although our knowledge on caveolae architecture and molecular composition has improved since their discovery, the main structural pillars defined at the time have not dramatically changed. Thus, today, caveolae are referred to as invaginations of the plasma membrane lipid bilayer, enriched in cholesterol and sphingolipids, embedding an integral membrane scaffold formed by caveolin oligomers assembled in a stable network, peripherally covered by a protein layer of cavin complexes. Once formed, this structure appears to remain stable also during endocytosis [46].
2. Caveolae signaling
The protein composition of caveolae has been addressed in a more systematic manner within the last years, using proteomic approaches [47-49]. A variety of signal transduction proteins were found to localize in caveolae, in tight connection with either the CSD or the lipid domains.
According to the caveolin signaling hypothesis, the role of caveolae is to trigger specific signal transduction by concentrating downstream effectors close to plasma membrane receptors, through direct interaction with the CSD [50,51]. Palmitoylation appears to play an important function in this process by facilitating the caveolar localization of proteins [52]. Of the signaling molecules identified, several have been more thoroughly investigated:
G proteins were abundant in caveolae; their binding to caveolin has a role in maintaining the Gα subunits in an inactive GDP-bound state [53]. Small GTP-binding proteins of the Ras superfamily also localized in caveolae, a process enhanced by palmitoylation of the C-terminal hypervariable region [54,55]. Binding of the H-Ras to the CSD results in inactivation of the protein, which is relevant in certain human cancers were H-Ras -caveolin interaction is prevented and the protein is maintained in an active state [56].
Src family kinases, such as c-Src, Fyn, Lyn [57] are nonreceptor tyrosine kinases, also enriched in caveolae. Their localization depends on the N-terminal myristoylation and subsequent interaction with the caveolins. Interestingly, Cav-1 palmitoylation is equally important for caveolae/c-Src interaction [52], which results in c-Src and Fyn inactivation [58]. In turn, the tyrosine phosphorylation of Cav-1 and -2 facilitates the recruitment of matrix metalloproteinases [58,59], and promotes caveolins localization to focal adhesions [60,61].
Several steroid hormone receptors were localized in caveolae, a process depending on both, palmitoylation and association with Cav-1 [62] and facilitating their activation [63].
Endothelial nitric oxide synthase (eNOS) is one of the most extensively studied Cav-1 interacting protein [64]. eNOS binds to the CSD of both Cav-1 and -3, which inhibit its enzymatic activity [65,66]. This observation lead to a novel concept of eNOS regulation, whereby, the interaction with caveolins is necessary to keep the enzyme inactive under basal conditions, while its concentration in caveolae will allow a quick response upon stimulation [67].
Many ion channels and pumps are targeted to caveolae and interact with caveolins, such as the calcium signaling molecules calmodulin, Ca2+-ATPase, L-type Ca2+ channels [68,69]. Transient receptor potential (TRP) channels, and large-conductance Ca2+-activated K+ channels also localize in cholesterol-rich membrane areas, suggesting an important role of these domains in Ca2+ homeostasis [70,71]. Other transporters, like the Na/K-ATPase, involved in maintaining the Na+ membrane gradient, are also found in caveolae, owing this localization to the existence of two caveolin-binding motifs in their amino acid sequence [72].
Protein kinases of different families were found in caveolae, due to their direct interaction with the Cav-1 CSD. For PKA, this interaction results in inhibition of the enzymatic activity [73], with consequences on regulation of other proteins, such as ATP-dependent K+ channels or eNOS in muscle and endothelial cells, respectively [74,75]. Different isoforms of the PKC family of enzymes are also caveolae resident and appear to participate in regulation of caveolar proteins [76]. Caveolae interaction with PKC is more complex, leading to either activation (via ceramide interaction) [77], or inactivation, following endosomal delivery [78]. Caveolae also recruit the phosphatidylinositol-3-kinase (PI3K) through direct binding to Cav-1 [79] and the protein kinase B (PKB). Integration of this signaling pathway by caveolae plays a significant role in managing the cellular physiological stress, and regulating cell survival and death [80].
Phosphodiesterases (PDEs), involved in cyclic nucleotides (cAMP and cGMP) hydrolysis, have a preference for lipid rafts association (Abrahamsen H, 2004). For some isoformes, such as PDE3B, a direct interaction with Cav-1, with a stabilizing effect on PDE3B, has been clearly confirmed by co-immunoprecipitation [81]. Other PDEs (PDE5, PDE4A4) appear to be recruited by caveoale through indirect mechanisms, possibly involving adapter proteins; [82]. Nevertheless, this association influences the establishment of cAMP/cGMP gradients and the downstream events [83].
3. Caveolae internalization and trafficking
Electron microscopy data show that caveolae are tightly connected to submembranous actin filaments [84,85], suggesting a function of the cytoskeleton in caveolae-mediated endocytosis. However, the exact role of the actin cytoskeleton is not clearly defined, as its disruption inhibits uptake of the caveolae ligand, alkaline phosphatase, on one hand [86] and promotes clustering of caveolae and internalization of Cav-1-labeled vesicles, on the other hand [6,87]. These observations fit into a model whereby actin would play a dual role in caveolae internalization: one is to keep the organization of caveolae and maintain their immobility at the plasma membrane, and the other to promote vesicle budding and release from the membrane.
Caveolae endocytosis relies heavily on dynamin, a multi-domain GTPase [88,89], which was shown to interact directly with Cav-1 [90]. Ligand binding initially disrupts the local actin cytoskeleton and promotes dynamin II recruitment to the site of internalization [91,92]. Dynamin oligomerization and the GTP-dependent conformational changes result in a structural collar around the neck of caveolae, directly mediating formation of free transport vesicles, following vesicular fission from the plasma membrane. It was shown that the protein regulates the actin tail formation [93,94], possibly through binding to cortactin [95-97] or intersectin, which promotes actin polymerization [98].
Another player in this complex molecular game was recently suggested, following the initial observation that Cav-1 binds to actin cross-linking proteins, filamin A and B, both
It was proposed that following budding, caveolae can fuse with either preformed vesicles, called “caveosome” at the time of their discovery, or early endosome, the latter process being dependent on Rab5 expression [46].
The caveosome was initially described as an immobile structure which did not co-localize with fluid phase markers or ligands of the clathrin-dependent pathway [104]. Moreover, the compartment was characterized by neutral pH and was unable to accumulate a lysosomal dye (lysotracker), reinforcing the notion of an independent organelle, clearly distinct from other endocytic compartments, which delivers its cargo to other cellular locations, such as the ER [104,105]. However, in a recent investigation of Cav-1 trafficking using pH-sensitive fluorophores, the existence of a neutral pH compartment was seriously doubted [106]. Rather, it was suggested that the caveosomes would correspond to modified late endosomes, where Cav-1 accumulates when over-expressed, undergoing ubiquitination and being further targeted to degradation [106]. Conversely, under physiological conditions, caveolae would bud from the plasma membrane transporting their viral cargo to early endosomes and eventually to the ER, in a microtubule-dependent manner [107], following a series of maturation events, which will be detailed below.
Clearly, more work is necessary to have the correct picture of the highly atypical caveolar trafficking, which appears to allow access of its ligands to intracellular destinations that are not reachable from other endocytic pathways. Despite the remaining uncertainties, the continuous development of the field has considerable advanced our knowledge of virus infection of host cells using caveolae endocytosis.
The current view of caveolae internalization and trafficking is depicted in Fig. 3.
4. Caveolae dependent viral infections
Owing to the vast amount of experimental data characterizing cell infection by the simian virus 40 (SV40), the pathogen has become the “star” of the caveolae-mediated entry pathway, being now extensively used in other studies as a marker of it [104,108]. Other well-characterized viruses using this entry pathway belong to the polyoma virus family, which has gained more interest recently, with the increasing number of human viruses identified. These include the KI polyoma virus, the WU polyoma virus and the Merkel cell polyoma virus [109-111], the latter being associated with an aggressive form of neuroendocrine skin cancer, the Merkel cell carcinoma. These are all non enveloped DNA viruses that replicate in the nucleus.
Viruses that use the same pathway to initiate a productive infection in target cells are listed in Table 1. Amongst them, Echovirus 1 (EV1), Human Hepatitis B virus (HBV) [112], Murine Leukemia Virus (MLV) [113], enteroviruses [114], have been more intensely investigated.
Simian virus 40 | Stang, E., J. Kartenbeck, and R.G. Parton. 1997. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Pelkmans, L., J. Kartenbeck, and A. Helenius. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. |
KI polyoma virus | Allander, T., K. Andreasson, S. Gupta, A. Bjerkner, G. Bogdanovic, M.A. Persson, T. Dalianis, T. Ramqvist, and B. Andersson. 2007. Identification of a third human polyomavirus. |
WU polyoma virus | Gaynor, A.M., M.D. Nissen, D.M. Whiley, I.M. Mackay, S.B. Lambert, G. Wu, D.C. Brennan, G.A. Storch, T.P. Sloots, and D. Wang. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. |
Merkel cell polyoma virus | Feng, H., M. Shuda, Y. Chang, and P.S. Moore. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. |
Echovirus 1 | Marjomaki, V., V. Pietiainen, H. Matilainen, P. Upla, J. Ivaska, L. Nissinen, H. Reunanen, P. Huttunen, T. Hyypia, and J. Heino. 2002. Internalization of echovirus 1 in caveolae. Stuart, A.D., H.E. Eustace, T.A. McKee, and T.D. Brown. 2002. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. |
Human Hepatitis B virus | Macovei, A., C. Radulescu, C. Lazar, S. Petrescu, D. Durantel, R.A. Dwek, N. Zitzmann, and N.B. Nichita. 2010. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. |
Murine Leukemia Virus | Beer, C., D.S. Andersen, A. Rojek, and L. Pedersen. 2005. Caveola-dependent endocytic entry of amphotropic murine leukemia virus. |
Tiger Frog Virus | Guo, C.J., D. Liu, Y.Y. Wu, X.B. Yang, L.S. Yang, S. Mi, Y.X. Huang, Y.W. Luo, K.T. Jia, Z.Y. Liu, W.J. Chen, S.P. Weng, X.Q. Yu, and J.G. He. 2011. Entry of tiger frog virus (an Iridovirus) into HepG2 cells via a pH-dependent, atypical, caveola-mediated endocytosis pathway. |
Infectious spleen and kidney necrosis virus | Guo, C.J., Y.Y. Wu, L.S. Yang, X.B. Yang, J. He, S. Mi, K.T. Jia, S.P. Weng, X.Q. Yu, and J.G. He. 2011. Infectious spleen and kidney necrosis virus (a fish iridovirus) enters Mandarin fish fry cells via caveola-dependent endocytosis. |
Influenza viruses | Nunes-Correia, I., A. Eulalio, S. Nir, and M.C. Pedroso de Lima. 2004. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. |
Coronavirus 229E | Nomura, R., A. Kiyota, E. Suzaki, K. Kataoka, Y. Ohe, K. Miyamoto, T. Senda, and T. Fujimoto. 2004. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. |
Papillomavirus 31 | Bousarghin, L., A. Touze, P.Y. Sizaret, and P. Coursaget. 2003. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. |
Respiratory syncytial virus | Brown G, Jeffree CE, McDonald T, Rixon HW, Aitken JD, et al. Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 2004;327(2) 175-185. Werling D, Hope JC, Chaplin P, Collins RA, Taylor G, et al. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol 1999;66(1) 50-58. |
Newcastle disease virus | Cantin, C., J. Holguera, L. Ferreira, E. Villar, and I. Munoz-Barroso. 2007. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. |
Ebola virus | Empig, C.J., and M.A. Goldsmith. 2002. Association of the caveola vesicular system with cellular entry by filoviruses. |
BK polyoma virus | Eash, S., W. Querbes, and W.J. Atwood. 2004. Infection of vero cells by BK virus is dependent on caveolae. |
Marburg virus | Empig, C.J., and M.A. Goldsmith. 2002. Association of the caveola vesicular system with cellular entry by filoviruses. |
After binding to the host cell, the virus particles are able to cluster the receptor molecules such as certain integrins (a2h1 in the case of EV1) [118] or glycosphingolipids (GM1 or GD1a in the case of SV40 or polyoma viruses), within the lipid rafts [119]. Accumulation of viral particles in caveolae induces a cascade of tyrosine phosphorylation reactions followed by rearrangements of the cortical actin cytoskeleton, as described above [91].
Several models addressing virus capturing into the plasma membrane invaginations have been proposed, the most recent relying on the observation that Cav-1 polymer remains intact once formed in the Golgi complex, during transport to the plasma membrane. According to this model, caveolae result from the fusion of a pre-existing caveolar vesicle with the plasma membrane [46]. As a consequence of virus binding to an increasing number of sphingolipids and/or integrins, the affinity of the pathogen for caveolar domains increases, facilitating entrapment in these areas. Another possibility is that virus particles bind and release the plasma membrane gangliosides in a transient manner, thus screening the whole cell surface. When reaching a caveolar region where multiple gangliosides interactions can occur simultaneously, binding becomes permanent and the virus particles are sequestered [104].
The intracellular trafficking of caveolae cargos has been recently re-evaluated using SV40 as a model and a series of complementary, state-of-the art techniques, including live-cells and electron microscopy, video recordings, pharmacological inhibitors and inhibition of expression of trafficking regulators [120]. It was shown that productive SV40 infection depends on the virus transport through a series of classical endocytic vesicles. Initially, the virus is found in Rab5-, EEA1-positive early endosomes and subsequently becomes associated with Rab7-positive domains, during endosome maturation. As this process proceeds, SV40 co-localizes with LAMP1-, Rab9-, and Rab7-positive late endosomes resembling multivesicular bodies and possibly endolysosomes. Endosome maturation also involves acidification of the compartments, as a consequence of vacuolar ATPase (v-ATPase) recruitment and activity. At this stage, acidification is required for SV40 subsequent transport steps and the initiation of productive infection. Interestingly, BK and JC viruses were also shown to enter the endosomes and depend on acidification for infection [121-123]. In the case of the mouse polyoma virus, the recycling, as well as late endosomes have been involved in infection [124,125].
From the late compartments of the endocytic pathway, SV40 appears to be directly transported to the ER, although an indirect ER targeting, via the Golgi complex, has not been completely excluded. Similarly, other polyoma viruses are transported to the ER lumen, before reaching the nucleus [121,125].
However, there are some notable exceptions of virus trafficking diverting from this pathway, despite being internalized through caveolae. Thus, cellular penetration of the EV1, a positive-stranded RNA human pathogen, depends on caveolins, dynamin II, and signaling events but does not require actin filaments or microtubules. The virus uptake was much faster than that of SV40 and was followed by rapid co-localization with Cav-1. Beyond this step, the virus failed to enter the Golgi complex, the ER, or the lysosomes, as none of the markers used to label these organelles co-localized with viral proteins. This observation raised the hypothesis that the virus particles remain sequestered in the Cav-1 positive endocytic vesicles until replication is initiated, further using them for cytoplasmic penetration and uncoating.
The lack of transport to the ER or Golgi was also confirmed by the absence of any inhibition of infection in the presence of nocodazole. Although more experimental data is needed to substantiate it, it is tempting to speculate that the different sorting pathway of the two viruses is related to their replication mechanism; thus, a DNA virus such as SV40 needs the nucleus for replication, which might be more accessible through the ER, whereas for a positive-stranded RNA virus the release of the genome into the cytoplasm is sufficient to initiate replication.
Either way, the precise molecular details characterizing this segment of the trafficking pathway are still to be defined, but understanding the factors involved in these unusual trafficking pathways is crucially important as other, yet uninvestigated viruses, may well use them when accessing the host cell via caveolae.
Importantly, there is accumulating evidence suggesting that several viruses take advantage of cross talk between endocytosis routes. For instance, JCV, bovine papillomavirus type 1 and human papillomavirus type 16 have been shown to access cells using the clathrin-dependent endocytosis, but intriguingly, they require Cav-1-mediated trafficking to initiate productive infection [123,126,127]. The internalized virions were trafficked to early endosomes before being transported to the caveolar pathway. From the Cav-1-positive vesicles, the viral cargo is further moved to the ER in a COPI-mediated, BFA-sensitive manner [127].
The newly described trafficking routes taken by these viruses may have an explanation in their absolute requirement to reach the ER compartment, a target that is not on the clathrin-mediated route.
The intriguing question as to why these viruses travel to the lumen of the ER, instead of using the endosomes for genome release, have received several interesting answers lately. One possibility is that the pathogens take advantage of the ER machinery of folding enzymes and chaperones, for uncoating and membrane penetration, being activated by lumenal thiol oxidoreductases before release into the cytosol/nucleoplasm [128].
Very recently, BiP and the ER-membrane protein BAP31 (both involved in ERAD) were shown to be essential factors for SV40 infection; thus incoming SV40 particles are structurally remodeled leading to exposure of the amino-terminal sequence of the minor viral protein VP2. These hydrophobic sequences anchor the virus to the ER membranes helping the particles release into the cytosol [129].
5. Investigation of the caveolae entry pathway
The molecular details of virus entry have been investigated through a variety of techniques, by perturbing endocytotic internalization with various inhibitors or interfering with the expression or function of key regulator proteins, using siRNA or dominant-negative mutants of the proteins, or by using transgenic animals. Because no single method to assess caveolae is perfect, the use of complementary techniques is crucial for such a task. These can employ cell fractionation, immunoprecipitation, protein and organelle labeling, immunofluorescence microscopy. Since caveolae are best characterized by their microscopic appearance, studies employing alteration of the intracellular level of caveolins, cholesterol, or different molecules enriched, but not exclusively present in caveolae, should ideally follow the impact of such changes to other internalization and trafficking pathways, by electron microscopy
5.1. Pharmacological approaches
A pharmacologic approach involves the treatment of cells with agents that deplete membranes of cholesterol, or inhibit various structural or signaling molecules involved in controlling the pathway. Having the advantage of being readily available and convenient to use, chemical inhibitors have been extensively employed to characterize different endocytic pathway; however, stringent controls must be included and results should be interpreted with care, because of the pleiotropic effects these drugs may have within the treated cell.
The usefulness as well as the pitfalls associated with the use of these agents will be detailed below.
A major issue of MβCD treatment is its cellular toxicity, which was initially associated with longer incubation times (for example, the cell viability decreases form 90% during a 30 minutes incubation, to as low as 64%, if the drug is used for 12 h) [117]. A thorough study performed on multiple cell lines showed, however, that MβCD significantly decreased cellular viability, even after short treatment and at concentrations routinely used to inhibit endocytosis, a phenomenon which was cell line dependent [136]. Moreover, a low level of plasma membrane cholesterol was shown to interfere with other endocytic pathways, such as the clathrin-mediated endocytosis [137,138], or even with cholesterol independent endocytosis [139], demonstrating a rather poor specificity of the drug in inhibiting a distinct pathway.
PMA has been shown to specifically inhibit the caveolae-mediated entry of Ebola and Marburg viruses, two negative-stranded RNA pathogens, members of the
It is important to note that PMA can stimulate endocytosis of other ligands and interferes with the endocytic trafficking by stimulating a factor required for endosome fusion after Rab5 activation [155]. PMA treatment may have opposite effects on internalization of certain ligands (such as FITC-dextran) in polarized cells, increasing for instance, its basolateral, but not apical uptake.
Depolymerization of microtubules with colchicine or disruption of actin microfilaments with cytochalasin D resulted in a significant reduction of the amount of Cav-3 in plasma membrane fractions isolated from cardiac myocytes. Treatment with either drug also led to the exclusion of Cav-1 and -2 from similar fractions and the decrease of tyrosine-phosphorylated Cav-1 [101].
Other drugs interfering with actin polymerization are latrunculin A (actin monomer-sequestering drug) and jasplakinolide (an actin polymer-stabilizing compound), both were shown to reduced SV40 internalization by more than 60% [91]. Since function of many cellular processes such as trafficking and organelle movement are regulated by microtubules and the actin cytoskeleton, the biochemical assays should be combined with microscopy analysis to clearly define the role of the cytoskeleton in viral infection mediated by caveolae. Also, it is important to keep in mind that viruses induce cytoskeletal reorganization and reconfiguration to initiate, maintain and spread the infection. Therefore, the impact of the cytoskeleton perturbation on the outcome of infection highly depends on the stage of the viral life cycle the drug is acting upon [158].
5.2. Interference with expression and function of caveolae regulating proteins
As threshold levels of Cav-1 regulate caveolae formation [155,159,160], modulating the expression and/or function of this protein is one the most reliable approach to investigate caveolae entry. Cav-1 down-regulation using anti-sense, small interfering (si) or short hairpin (sh) RNA results in a significant decrease in the number of caveolae. For instance, the siRNA-mediated knockdown of Cav-1 expression was sufficient to inhibit albumin uptake in endothelial cells; however, intriguingly enough, the caveolae localization of signaling proteins, including eNOS, Rac, tyrosine kinase Src and insulin receptor was not altered. Using this technique, several viruses were shown to depend on caveolae for productive infection such as the Avian Reovirus [161], BK polyomavirus [133].
Cavin proteins are also important targets to study caveolae-mediated entry, since absence of cavin-1 results in lower expression level of caveolins and eventually, the loss of caveole. Down-regulation of cavin-1, using specific shRNA, increases mobility of caveolin-1, which is released from the cell surface and rapidly internalized and degraded [39]. Interfering with cavin-2 expression is also a valuable tool when assessing the role of caveolae in viral infection, since its down-regulation induces loss of cavin-1 and caveolin expression and therefore, it limits caveolae formation [43]. Similarly, suppression of cavin-3 biosynthesis uncouples caveolae from the intracellular transport machinery [44].
Caveolae budding from the plasma membrane and subsequent internalization strictly depends on dynamin II [89], thus silencing its expression is also often used in combination with caveolin inhibition.
An elegant alternative to silencing the expression of the proteins involved in caveolae architecture and function is over-expression of their mutant counterparts, which compete with the wild-type proteins for the same function. An important advantage of this technique is that, at any time during the experiment, the wild-type protein is still expressed ensuring the functioning of the pathway at a basal level and reducing toxicity. This approach was used to show the dependence of HBV internalization on functional Cav-1 and dynamin II (Fig. 4) [112].
Other caveolin constructs containing the point mutations, Y14F and P132L were recently demonstrated to have dominant-negative activity [166]. Expression of the Cav-1 variant containing the P110A mutation was shown to determine a profound inhibition of caveolae endocytosis, cellular lipid accumulation and lipid droplet biogenesis. Moreover, this is a potent mutant to take into account when investigating the caveolae pathway, as it significantly reduces the Cav-1 localization into detergent-resistant domains of the plasma membrane and caveolae formation [22].
An interesting caveolin mutant is cavDGV, a deleted Cav-3 form, which lacks the first 53 residues of the protein, but contains an intact scaffolding domain. The truncated protein acts as a dominant negative inhibitory mutant, causing the intracellular accumulation of free cholesterol in late endosomes, a reduction of surface cholesterol, efflux and synthesis [30].
A long term expression of a dominant negative protein may be toxic for the cells, determining changes of morphology. Also it is important to keep in mind that down-regulation of a certain pathway may promote up-regulation of other, compensatory entry mechanisms, if cells express dominant negative proteins for a long time. A solution to overcome these potential problems is the use controlled/inducible expression systems (such as the TetOn/Tet Off switch).
6. Concluding remarks
The new experimental evidence emerged with the advance of the techniques used to investigate ligand internalization and intracellular trafficking, have consolidated the notion that endocytosis through caveolae is a true alternative to the clathrin-mediated pathway. By employing this route for entry into the target cell, viruses could benefit from the enormous advantage of being targeted directly to specific organelles that are essential for their replication; moreover, degradative compartments can be bypassed, which could enhance the efficiency of productive infection. Nevertheless, despite the tremendous development of the field in the last decade, many conceptual and mechanistic aspects are still to be clarified or reevaluated. Certainly, important issues regarding: a) the regulation of the crosstalk between different internalization pathways; b) the similarities between caveolae and other clathrin-independent entry routes; c) the exact mechanism of ligand sorting; d) the properties of the compartment(s) where it occurs; d) the preferential targeting of caveolae ligands to other intracellular compartments than the ER; are already under the scrutiny of many cell biologists and will find an answer in the near future.
Acknowledgement
This work was supported by the Romanian Academy project 3 of the Institute of Biochemistry, the IDEI grant ID-84 and the POSDRU/89/1.5/S/60746 grant.
References
- 1.
Palade GE. Caveolae-Dependent Endocytosis in Viral Infection . J Histochem Cytochem1 1953 4 188 211 . - 2.
Yamada E. Caveolae-Dependent Endocytosis in Viral Infection . J Biophys Biochem Cytol1 1955 6 551 566 . - 3.
Stan R. V. Roberts W. G. Predescu D. Ihida K. Saucan L. et al. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell8 1997 4 595 605 . - 4.
Montesano R. Roth J. Robert A. Orci L. Caveolae-Dependent Endocytosis in Viral Infection 296 1982 5858 651 653 . - 5.
J Cell BiolParton R. G. Way M. Zorzi N. Stang E. Caveolin associates with. developing T-tubules. during muscle. differentiation 136 1997 1 137 154 . - 6.
Thomsen P. Roepstorff K. Stahlhut M. van Deurs B. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell13 2002 1 238 250 . - 7.
Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, et al. Caveolin, a protein component of caveolae membrane coats. 68 1992 4 673 682 . - 8.
Implications for the molecular evolution of mammalian caveolin genes. J Biol ChemTang Z. Okamoto T. Boontrakulpoontawee P. Katada T. Otsuka A. J. et al. Identification sequence. expression of. an invertebrate. caveolin gene. family from. the nematode. Caenorhabditis elegans. 272 1997 4 2437 2445 . - 9.
Scherer P. E. Lewis R. Y. Volonte D. Engelman J. A. Galbiati F. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem 1997;272 46 29337 29346 . - 10.
Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol ChemSong K. S. Scherer P. E. Tang Z. Okamoto T. Li S. et al. Expression of. caveolin in skeletal. cardiac smooth muscle. cells 271 1996 25 15160 15165 . - 11.
Tang Z. Scherer P. E. Okamoto T. Song K. Chu C. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem271 1996 4 2255 2261 . - 12.
FEBS LettWay M. Parton R. G. M-caveolin a. muscle-specific caveolin-related. protein F. E. B. 1995 108 EOF 12 EOF . - 13.
Li S. Song K. S. Lisanti M. P. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem271 1996 1 568 573 . - 14.
Fujimoto T. Kogo H. Nomura R. Une T. Isoforms of. caveolin caveolar structure. J. Cell Sci. 2000 Pt19 3509 . - 15.
FEBS Lett 2003;538(1-3) 85-88.Lahtinen U. Honsho M. Parton R. G. Simons K. Verkade P. Involvement of. caveolin in caveolar. biogenesis in. M. D. C. K. cells F. E. B. - 16.
Sowa G. Pypaert M. Fulton D. Sessa W. C. Caveolae-Dependent Endocytosis in Viral Infection . Proc Natl Acad Sci U S A 2003;100 11 6511 6516 . - 17.
Trends Mol MedGalbiati F. Razani B. Lisanti M. P. Caveolae caveolin in muscular. dystrophy 7 2001 10 435 441 . - 18.
Dupree P. Parton R. G. Raposo G. Kurzchalia T. V. Simons K. Caveolae-Dependent Endocytosis in Viral Infection Embo J12 1993 4 1597 1605 . - 19.
Mol Biol CellMonier S. Parton R. G. Vogel F. Behlke J. Henske A. et al. V. I. P21-caveolin a. membrane protein. constituent of. the caveolar. coat oligomerizes. in vivo. in vitro. 6 1995 7 911 927 . - 20.
The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J Biol ChemSchlegel A. Schwab R. B. Scherer P. E. Lisanti M. P. A. role for. the caveolin. scaffolding domain. in mediating. the membrane. attachment of. caveolin- 274 1999 32 22660 22667 . - 21.
Arbuzova A. Wang L. Wang J. Hangyas-Mihalyne G. Murray D. et al. Caveolae-Dependent Endocytosis in Viral Infection 39 2000 33 10330 10339 . - 22.
Aoki S. Thomas A. Decaffmeyer M. Brasseur R. Epand R. M. Caveolae-Dependent Endocytosis in Viral Infection . J Biol Chem285 2010 43 33371 33380 . - 23.
Lee J. Glover K. J. Caveolae-Dependent Endocytosis in Viral Infection . Biochim Biophys Acta1818 2012 5 1158 1164 . - 24.
Fernandez I. Ying Y. Albanesi J. Anderson R. G. Caveolae-Dependent Endocytosis in Viral Infection . Proc Natl Acad Sci U S A99 2002 17 11193 11198 . - 25.
Sargiacomo M. Scherer P. E. Tang Z. Kubler E. Song K. S. et al. Caveolae-Dependent Endocytosis in Viral Infection Proc Natl Acad Sci U S A92 1995 20 9407 9411 . - 26.
Ren X. Ostermeyer A. G. Ramcharan L. T. Zeng Y. Lublin D. M. et al. Caveolae-Dependent Endocytosis in Viral Infection . Mol Biol Cell15 2004 10 4556 4567 . - 27.
Song K. S. Tang Z. Li S. Lisanti M. P. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem272 1997 7 4398 4403 . - 28.
Monier S. Dietzen D. J. Hastings W. R. Lublin D. M. Kurzchalia T. V. Caveolae-Dependent Endocytosis in Viral Infection FEBS Lett1996 143-149. - 29.
Ostermeyer A. G. Paci J. M. Zeng Y. Lublin D. M. Munro S. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol152 2001 5 1071 1078 . - 30.
J Cell BiolPol A. Luetterforst R. Lindsay M. Heino S. Ikonen E. et al. A. caveolin dominant. negative mutant. associates with. lipid bodies. induces intracellular. cholesterol imbalance. 152 2001 5 1057 1070 . - 31.
Scheiffele P. Verkade P. Fra A. M. Virta H. Simons K. et al. Caveolin 2 in the exocytic pathway of MDCK cells. J Cell Biol 1998;140 4 795 806 . - 32.
Lee H. DS Park Wang. X. B. Scherer P. E. Schwartz P. E. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem2002 34556-34567. - 33.
J Biol ChemMora R. Bonilha V. L. Marmorstein A. Scherer P. E. Brown D. et al. Caveolin localizes to. the golgi. complex but. redistributes to. plasma membrane. caveolae rafts when. co-expressed with. caveolin- 274 1999 36 25708 25717 . - 34.
Hayer A. Stoeber M. Bissig C. Helenius A. Biogenesis of. caveolae stepwise. assembly of. large caveolin. cavin complexes. 11 2010 3 361 382 . - 35.
Murata M. Peranen J. Schreiner R. Wieland F. Kurzchalia T. V. et al. V. I. Caveolae-Dependent Endocytosis in Viral Infection . Proc Natl Acad Sci U S A92 1995 22 10339 10343 . - 36.
Ortegren U. Karlsson M. Blazic N. Blomqvist M. Nystrom F. H. et al. Caveolae-Dependent Endocytosis in Viral Infection . Eur J Biochem271 2004 10 2028 2036 . - 37.
Proc Natl Acad Sci U S AFielding C. J. Bist A. Fielding P. E. Caveolin m. R. N. A. levels are. up-regulated by. free cholesterol. down-regulated by. oxysterols in. fibroblast monolayers. 94 1997 8 3753 3758 . - 38.
Frank P. G. Marcel Y. L. MA Connelly Lublin. D. M. Franklin V. et al. Stabilization of. caveolin by cellular. cholesterol scavenger receptor. class B. type I. 41 2002 39 11931 11940 . - 39.
MM Hill Bastiani. M. Luetterforst R. Kirkham M. Kirkham A. et-Cavin al. P. T. R. F. conserved a. cytoplasmic protein. required for. caveola formation. function 132 2008 1 113 124 . - 40.
Cell MetabLiu L. Brown D. Mc Kee M. Lebrasseur N. K. Yang D. et al. Deletion of. Cavin P. T. R. F. causes global. loss of. caveolae dyslipidemia. glucose intolerance. 8 2008 4 310 317 . - 41.
Aboulaich N. Vainonen J. P. Stralfors P. Vener A. V. Caveolae-Dependent Endocytosis in Viral Infection . Biochem J2004 2) 237-248. - 42.
Jedrychowski MP, Nixon SJ, et al.Bastiani M. Liu L. MM Hill Jedrychowski. M. P. Nixon S. J. et al. M. U. R. C. Cavin cavin family. members form. tissue-specific caveolar. complexes Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol185 2009 7 1259 1273 . - 43.
Nat Cell BiolHansen C. G. Bright N. A. Howard G. Nichols B. J. S. D. P. R. induces membrane. curvature functions in. the formation. of caveolae. 11 2009 7 807 814 . - 44.
Embo JMc Mahon K. A. Zajicek H. Li W. P. MJ Peyton Minna. JD et al. S. R. B. C/cavin is a. caveolin adapter. protein that. regulates caveolae. function 28 2009 8 1001 1015 . - 45.
Zimmerberg J. MM Kozlov Caveolae-Dependent Endocytosis in Viral Infection Nat Rev Mol Cell Biol7 2006 1 9 19 . - 46.
Pelkmans L. Burli T. Zerial M. Helenius A. Caveolae-Dependent Endocytosis in Viral Infection 118 2004 6 767 780 . - 47.
Banfi C. Brioschi M. Wait R. Begum S. Gianazza E. et al. Caveolae-Dependent Endocytosis in Viral Infection 6 2006 6 1976 1988 . - 48.
Mc Mahon K. A. Zhu M. Kwon S. W. Liu P. Zhao Y. et al. Caveolae-Dependent Endocytosis in Viral Infection 6 2006 1 143 152 . - 49.
Durr E. Yu J. Krasinska K. M. Carver L. A. Yates J. R. et al. Caveolae-Dependent Endocytosis in Viral Infection Nat Biotechnol22 2004 8 985 992 . - 50.
Ostrom RS, Insel PA. Caveolae-Dependent Endocytosis in Viral Infection Br J Pharmacol143 2004 2 235 245 . - 51.
Cohen A. W. Razani B. Schubert W. Williams T. M. Wang X. B. et al. Role of. caveolin in the. modulation of. lipolysis lipid droplet. formation 53 2004 5 1261 1270 . - 52.
JA, Volonte D, Galbiati F, et al.Lee H. Woodman S. E. Engelman J. A. Volonte D. Galbiati F. et al. Palmitoylation of. caveolin at a. single site. . Cys-15 controls its. coupling to. the-Src c. tyrosine kinase. targeting of. dually acylated. molecules . G. P. I-linked transmembrane. or cytoplasmic. to caveolae. effectively-Src uncouples. c. caveolin R-14 . T. Y. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem276 2001 37 35150 35158 . - 53.
Insel PA, Head BP, Ostrom RS, Patel HH, Swaney JS, et al. Caveolae-Dependent Endocytosis in Viral Infection Ann N Y Acad Sci1047 166 . - 54.
Roy S. Plowman S. Rotblat B. Prior I. A. Muncke C. et al. Caveolae-Dependent Endocytosis in Viral Infection . Mol Cell Biol25 2005 15 6722 6733 . - 55.
Prior I. A. Harding A. Yan J. Sluimer J. Parton R. G. et al. G. T. Caveolae-Dependent Endocytosis in Viral Infection Nat Cell Biol3 2001 4 368 375 . - 56.
Li S. Okamoto T. Chun M. Sargiacomo M. Casanova J. E. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem270 1995 26 15693 15701 . - 57.
Sargiacomo M. Sudol M. Tang Z. Lisanti M. P. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol122 1993 4 789 807 . - 58.
Li S. Couet J. Lisanti M. P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. 271 1996 46 29182 29190 . - 59.
Lee H. Volonte D. Galbiati F. Iyengar P. Lublin D. M. et al. Caveolae-Dependent Endocytosis in Viral Infection Mol Endocrinol 2000;14 11 1750 1775 . - 60.
Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J Biol ChemSwaney J. S. Patel H. H. Yokoyama U. Head B. P. Roth D. M. et al. 281 2006 25 17173 17179 . - 61.
Del Pozo MA, Schwartz MA. Rac, membrane heterogeneity, caveolin and regulation of growth by integrins. Trends Cell Biol17 2007 5 246 250 . - 62.
Does palmitoylation target estrogen receptors to plasma membrane caveolae? IUBMB LifeAcconcia F. Bocedi A. Ascenzi P. Marino M. 55 2003 1 33 35 . - 63.
Li L. Ren C. H. Tahir S. A. Ren C. Thompson T. C. Caveolin maintains activated. Akt in. prostate cancer. cells through. scaffolding domain. binding site. interactions with. inhibition of. serine/threonine protein. phosphatases P. 1 1 and PP2A. Mol Cell Biol 2003;23(24) 9389-9404. - 64.
Garcia-Cardena G. Fan R. Stern D. F. Liu J. Sessa W. C. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem271 1996 44 27237 27240 . - 65.
Venema V. J. Ju H. Zou R. Venema R. C. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem272 1997 45 28187 28190 . - 66.
Garcia-Cardena G. Martasek P. BS Masters Skidd. P. M. Couet J. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem272 1997 41 25437 25440 . - 67.
Sbaa E. Frerart F. Feron O. Caveolae-Dependent Endocytosis in Viral Infection Trends Cardiovasc Med15 2005 5 157 162 . - 68.
Function of caveolaeIsshiki M. Anderson R. G. 2 Ca2+ entry and Ca2+-dependent signal transduction. Traffic 2003;4 11 717 723 . - 69.
Bergdahl A. Sward K. Caveolae-Dependent Endocytosis in Viral Infection Can J Physiol Pharmacol82 2004 5 289 299 . - 70.
Caveolae targeting and regulation of large conductance Ca(2+)-activated K+ channels in vascular endothelial cells. J Biol ChemWang X. L. Ye D. Peterson T. E. Cao S. Shah V. H. et al. 280 2005 12 11656 11664 . - 71.
Darby PJ, Kwan CY, Daniel EE. Caveolae-Dependent Endocytosis in Viral Infection . Am J Physiol Lung Cell Mol Physiol 2000;279(6) L1226 1235 . - 72.
Beta-subunit of cardiac Na+-K+-ATPase dictates the concentration of the functional enzyme in caveolae. Am J Physiol Cell PhysiolLiu L. Askari A. 2006 C569 578 . - 73.
Am J Physiol Cell PhysiolRazani B. Lisanti M. P. Two distinct. caveolin domains mediate. the functional. interaction of. caveolin with protein. kinase A. 2001 C1241 1250 . - 74.
Sampson L. J. Hayabuchi Y. Standen N. B. Dart C. Caveolae-Dependent Endocytosis in Viral Infection Circ Res95 2004 10 1012 1018 . - 75.
JD, Bowler RP, Akkerman JW, et al.Heijnen H. F. Waaijenborg S. JD Crapo Bowler. R. P. Akkerman J. W. et al. Colocalization of. e. N. O. S. the catalytic. subunit of. P. K. A. in endothelial. cell junctions. a. clue for. regulated N. O. production Caveolae-Dependent Endocytosis in Viral Infection J Histochem Cytochem52 2004 10 1277 1285 . - 76.
Peart JN, Headrick JP. Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114 2007 2 208 221 . - 77.
Fox T. E. Houck K. L. O’Neill S. M. Nagarajan M. Stover T. C. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem282 2007 17 12450 12457 . - 78.
Joubert D, Parker PJ. Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment. J Cell SciPrevostel C. Alice V. Joubert D. Parker P. J. Protein kinase. C(alpha actively. downregulates through. caveolae-dependent traffic. to an. endosomal compartment. 2000 ( Pt 14) 2575-2584. - 79.
Cell Mol Biol LettKrajewska W. M. Maslowska I. Caveolins structure. function in. signal transduction. 9 2004 2 195 220 . - 80.
Circ ResSedding D. G. Hermsen J. Seay U. Eickelberg O. Kummer W. et al. Caveolin facilitates mechanosensitive. protein kinase. B. . Akt signaling. in vitro. in vivo. 96 2005 6 635 642 . - 81.
Nilsson R. Ahmad F. Sward K. Andersson U. Weston M. et al. Caveolae-Dependent Endocytosis in Viral Infection . Cell Signal 2006;18 10 1713 1721 . - 82.
Role of O(2)-sensitive K(+) andMurray F. Insel P. A. Yuan J. X. 2 channels in the regulation of the pulmonary circulation: potential role of caveolae and implications for high altitude pulmonary edema. Respir Physiol Neurobiol 2006;151(2-3) 192-208. - 83.
Houslay MD, Baillie GS, Maurice DH. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling. Circ Res100 2007 7 950 966 . - 84.
Morone N. Fujiwara T. Murase K. Kasai R. S. Ike H. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol174 2006 6 851 862 . - 85.
Richter T. Floetenmeyer M. Ferguson C. Galea J. Goh J. et al. High-resolution . D. quantitative analysis. of caveolar. ultrastructure caveola-cytoskeleton interactions. 9 2008 6 893 909 . - 86.
Parton R. G. Joggerst B. Simons K. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol127 1994 5 1199 1215 . - 87.
Mundy D. I. Machleidt T. Ying Y. S. Anderson R. G. Bloom G. S. Caveolae-Dependent Endocytosis in Viral Infection J Cell Sci2002 22)4327 EOF 39 EOF . - 88.
Henley JR, Krueger EW, Oswald BJ, McNiven MA. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol141 1998 1 85 99 . - 89.
Oh P. Mc Intosh D. P. Schnitzer J. E. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol141 1998 1 101 114 . - 90.
J, Cao H, Orth JD, McCaffery JM, et al.Yao Q. Chen J. Cao H. JD Orth Mc Caffery. J. M. et al. Caveolin interacts directly. with dynamin-. Caveolae-Dependent Endocytosis in Viral Infection J Mol Biol348 2005 2 491 501 . - 91.
Pelkmans L. Puntener D. Helenius A. Caveolae-Dependent Endocytosis in Viral Infection .296 2002 5567 535 539 . - 92.
Sharma D. K. Brown J. C. Choudhury A. Peterson T. E. Holicky E. et al. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell15 2004 7 3114 3122 . - 93.
Lee E. De Camilli P. Caveolae-Dependent Endocytosis in Viral Infection . Proc Natl Acad Sci U S A99 2002 1 161 166 . - 94.
JD Orth Krueger. E. W. Cao H. MA Mc Niven Caveolae-Dependent Endocytosis in Viral Infection . Proc Natl Acad Sci U S A99 2002 1 167 172 . - 95.
MA Mc Niven Kim. L. Krueger E. W. JD Orth Cao. H. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol151 2000 1 187 198 . - 96.
Schafer D. A. Weed S. A. Binns D. Karginov A. V. Parsons J. T. et al. Caveolae-Dependent Endocytosis in Viral Infection Curr Biol 2002;12 21 1852 1857 . - 97.
Mol Biol CellKrueger E. W. JD Orth Cao. H. MA Mc Niven A. dynamin-cortactin-Arp2 complex mediates. actin reorganization. in growth. factor-stimulated cells. 14 2003 3 1085 1096 . - 98.
Predescu SA, Predescu DN, Timblin BK, Stan RV, Malik AB. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell14 2003 12 4997 5010 . - 99.
Stahlhut M. van Deurs B. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell11 2000 1 325 337 . - 100.
MA Doucey Bender. F. C. Hess D. Hofsteenge J. Bron C. Caveolin interacts with. the chaperone. complex T. C. 1 and modulates its protein folding activity. Cell Mol Life Sci 2006;63(7-8)939 EOF 948 EOF . - 101.
Head B. P. Patel H. H. Roth D. M. Murray F. Swaney J. S. et al. Caveolae-Dependent Endocytosis in Viral Infection J Biol Chem281 2006 36 26391 26399 . - 102.
Exp Cell ResRavid D. Chuderland D. Landsman L. Lavie Y. Reich R. et al. Filamin A. is a. novel caveolin-1-dependent. target-I-stimulated in. I. G. F. cancer cell. migration 314 2008 15 2762 2773 . - 103.
Mol Biol CellSverdlov M. Shinin V. Place A. T. Castellon M. Minshall R. D. Filamin A. regulates caveolae. internalization trafficking in. endothelial cells. 20 2009 21 4531 4540 . - 104.
Pelkmans L. Kartenbeck J. Helenius A. Caveolae-Dependent Endocytosis in Viral Infection Nat Cell Biol3 2001 5 473 483 . - 105.
Le PU, Nabi IR. Caveolae-Dependent Endocytosis in Viral Infection J Cell Sci2003 6)1059 EOF 71 EOF . - 106.
J Cell BiolHayer A. Stoeber M. Ritz D. Engel S. Meyer H. H. et al. Caveolin is ubiquitinated. targeted to. intralumenal vesicles. in endolysosomes. for degradation. 191 2010 3 615 629 . - 107.
Gilbert J. Benjamin T. Caveolae-Dependent Endocytosis in Viral Infection 1 J Virol 2004;78 22 12259 12267 . - 108.
Stang E. Kartenbeck J. Parton R. G. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell 1997;8 1 47 57 . - 109.
Allander T. Andreasson K. Gupta S. Bjerkner A. Bogdanovic G. et al. Caveolae-Dependent Endocytosis in Viral Infection J Virol81 2007 8 4130 4136 . - 110.
Feng H. Shuda M. Chang Y. Moore P. S. Caveolae-Dependent Endocytosis in Viral Infection .319 2008 5866 1096 1100 . - 111.
Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, et al. Caveolae-Dependent Endocytosis in Viral Infection . PLoS Pathog2007 e64. - 112.
J VirolMacovei A. Radulescu C. Lazar C. Petrescu S. Durantel D. et al. Hepatitis B. virus requires. intact caveolin. function for. productive infection. in Hepa. R. G. cells 84 2010 1 243 253 . - 113.
Beer C. DS Andersen Rojek. A. Pedersen L. Caveolae-Dependent Endocytosis in Viral Infection J Virol79 2005 16 10776 10787 . - 114.
J VirolStuart A. D. Eustace H. E. Mc Kee T. A. Brown T. D. A. novel cell. entry pathway. for a. D. A. F-using human. enterovirus is. dependent on. lipid rafts. 76 2002 18 9307 9322 . - 115.
Brown G. CE Jeffree Mc Donald. T. Rixon H. W. JD Aitken et. al Caveolae-Dependent Endocytosis in Viral Infection . 2004;327 2 175 185 . - 116.
Werling D. Hope J. C. Chaplin P. Collins R. A. Taylor G. et al. Caveolae-Dependent Endocytosis in Viral Infection J Leukoc Biol66 1999 1 50 58 . - 117.
Cantin C. Holguera J. Ferreira L. Villar E. Munoz-Barroso I. Caveolae-Dependent Endocytosis in Viral Infection J Gen Virol2007 2)559 EOF 69 EOF . - 118.
Marjomaki V. Pietiainen V. Matilainen H. Upla P. Ivaska J. et al. Caveolae-Dependent Endocytosis in Viral Infection J Virol 2002;76 4 1856 1865 . - 119.
Tsai B. Gilbert J. M. Stehle T. Lencer W. Benjamin T. L. et al. Caveolae-Dependent Endocytosis in Viral Infection 40 Embo J 2003;22 17 4346 4355 . - 120.
Engel S. Heger T. Mancini R. Herzog F. Kartenbeck J. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Virol 2011;85 9 4198 4211 . - 121.
Jiang M. Abend J. R. Tsai B. MJ Imperiale Caveolae-Dependent Endocytosis in Viral Infection . J Virol83 2009 3 1350 1358 . - 122.
Liebl D. Difato F. Hornikova L. Mannova P. Stokrova J. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Virol80 2006 9 4610 4622 . - 123.
Querbes W. BA O’Hara Williams. G. Atwood W. J. Caveolae-Dependent Endocytosis in Viral Infection J Virol80 2006 19 9402 9413 . - 124.
Mannova P. Forstova J. Caveolae-Dependent Endocytosis in Viral Infection J Virol77 2003 3 1672 1681 . - 125.
PLoS PathogQian M. Cai D. Verhey K. J. Tsai B. A. lipid receptor. sorts polyomavirus. from the. endolysosome to. the endoplasmic. reticulum to. cause infection. P. Lo 2009 e1000465. - 126.
Laniosz V. Holthusen K. A. Meneses P. I. Caveolae-Dependent Endocytosis in Viral Infection . J Virol 2008;82 13 6288 6298 . - 127.
Laniosz V. Dabydeen S. A. MA Havens Meneses. P. I. Caveolae-Dependent Endocytosis in Viral Infection . J Virol83 2009 16 8221 8232 . - 128.
Schelhaas M. Malmstrom J. Pelkmans L. Haugstetter J. Ellgaard L. et al. Simian Virus. . depends on. E. R. protein folding. quality control. factors for. entry into. host cells. 131 2007 3 516 529 . - 129.
Geiger R. Andritschke D. Friebe S. Herzog F. Luisoni S. et al. B. A. Caveolae-Dependent Endocytosis in Viral Infection Nat Cell Biol 2011;13 11 1305 1314 . - 130.
Pitha J. Irie T. Sklar P. B. Nye J. S. Caveolae-Dependent Endocytosis in Viral Infection Life Sci43 1988 6 493 502 . - 131.
Hussain KM, Leong KL, Ng MM, Chu JJ. Caveolae-Dependent Endocytosis in Viral Infection 71 J Biol Chem286 1 309 321 . - 132.
J.Van Hamme E. Dewerchin H. L. Cornelissen E. Verhasselt B. Nauwynck H. J. Clathrin caveolae-independent entry. of feline. infectious peritonitis. virus in. monocytes depends. on dynamin. Caveolae-Dependent Endocytosis in Viral Infection . J Gen Virol2008 9)2147 EOF 2158 EOF -2156. - 133.
Moriyama T. Marquez J. P. Wakatsuki T. Sorokin A. Caveolae-Dependent Endocytosis in Viral Infection J Virol81 2007 16 8552 8562 . - 134.
J VirolMacovei A. Radulescu C. Lazar C. Petrescu S. Durantel D. et al. Hepatitis B. virus requires. intact caveolin. function for. productive infection. in Hepa. R. G. cells 84 841 1 243 253 . - 135.
Spoden G. Freitag K. Husmann M. Boller K. Sapp M. et al. Clathrin caveolin-independent entry. of human. papillomavirus type. 16--involvement of. tetraspanin-enriched microdomains. . T. E. Ms Lo P. 2008 e3313 EOF . - 136.
Vercauteren D. Vandenbroucke R. E. Jones A. T. Rejman J. Demeester J. et al. Caveolae-Dependent Endocytosis in Viral Infection . Mol Ther18 2010 3 561 569 . - 137.
Rodal S. K. Skretting G. Garred O. Vilhardt F. van Deurs B. et al. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell10 1999 4 961 974 . - 138.
Krey T. Thiel H. J. Rumenapf T. Caveolae-Dependent Endocytosis in Viral Infection J Virol79 2005 7 4191 4200 . - 139.
Imelli N. Meier O. Boucke K. Hemmi S. Greber U. F. Caveolae-Dependent Endocytosis in Viral Infection 2 J Virol 2004;78 6 3089 3098 . - 140.
Liao JK. Caveolae-Dependent Endocytosis in Viral Infection Curr Opin Lipidol16 2005 6 624 629 . - 141.
Holschermann H. Schuster D. Parviz B. Haberbosch W. Tillmanns H. et al. Statins prevent. N. F-kappa B. transactivation independently. of the. I. K. K-pathway in. human endothelial. cells 185 2006 2 240 245 . - 142.
Sun D. Fernandes G. Caveolae-Dependent Endocytosis in Viral Infection Cell Immunol223 2003 1 52 62 . - 143.
How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys ActaBolard J. 1986 257-304. - 144.
Orlandi PA, Fishman PH. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol141 1998 4 905 915 . - 145.
Schnitzer J. E. Oh P. Pinney E. Allard J. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Biol127 1994 5 1217 1232 . - 146.
von Gersdorff. K. Sanders N. N. Vandenbroucke R. De Smedt S. C. Wagner E. et al. Caveolae-Dependent Endocytosis in Viral Infection Mol Ther14 2006 5 745 753 . - 147.
Dangoria NS, Breau WC, Anderson HA, Cishek DM, Norkin LC. Caveolae-Dependent Endocytosis in Viral Infection J Gen Virol199677 ( Pt 9)2173 EOF 82 EOF . - 148.
Li E. Stupack D. G. Brown S. L. Klemke R. Schlaepfer D. D. et al. Association of. p1 C. A. 130CAS 130 with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J Biol Chem 2000;275(19) 14729-14735. - 149.
Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J VirolSharma-Walia N. Naranatt P. P. Krishnan H. H. Zeng L. Chandran B. 78 2004 8 4207 4223 . - 150.
Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex. TrafficCubells L. Vila de Muga. S. Tebar F. Wood P. Evans R. et al. 8 2007 11 1568 1589 . - 151.
Anderson RG. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A90 1993 23 10909 10913 . - 152.
Anderson H. A. Chen Y. Norkin L. C. Caveolae-Dependent Endocytosis in Viral Infection Mol Biol Cell7 1996 11 1825 1834 . - 153.
J.Pho M. T. Ashok A. Atwood W. J. J. C. virus enters. human glial. cells by. clathrin-dependent receptor-mediated. endocytosis Caveolae-Dependent Endocytosis in Viral Infection J Virol74 2000 5 2288 2292 . - 154.
Empig CJ, Goldsmith MA. Caveolae-Dependent Endocytosis in Viral Infection . J Virol76 2002 10 5266 5270 . - 155.
Aballay A. Stahl P. D. Mayorga L. S. Caveolae-Dependent Endocytosis in Viral Infection J Cell Sci1999 ( Pt 15)2549 EOF 57 EOF . - 156.
Trends Biochem SciCohen P. Holmes C. F. Tsukitani Y. Okadaic acid. a. new probe. for the. study of. cellular regulation. 15 1990 3 98 102 . - 157.
Lajoie P. Nabi I. R. Caveolae-Dependent Endocytosis in Viral Infection . J Cell Mol Med11 2007 4 644 653 . - 158.
Taylor MP, Koyuncu OO, Enquist LW. Caveolae-Dependent Endocytosis in Viral Infection . Nat Rev Microbiol9 2011 6 427 439 . - 159.
Breuza L. Corby S. Arsanto J. P. Delgrossi M. H. Scheiffele P. et al. Caveolae-Dependent Endocytosis in Viral Infection J Cell Sci 2002;115(Pt 23)4457 EOF 67 EOF . - 160.
Hailstones D. Sleer L. S. Parton R. G. Stanley K. K. Caveolae-Dependent Endocytosis in Viral Infection J Lipid Res39 1998 2 369 379 . - 161.
Huang W. R. Wang Y. C. Chi P. I. Wang L. Wang C. Y. et al. Caveolae-Dependent Endocytosis in Viral Infection . J Biol Chem 2011;286(35) 30780-30794. - 162.
Trouet D. Hermans D. Droogmans G. Nilius B. Eggermont J. Caveolae-Dependent Endocytosis in Viral Infection . Biochem Biophys Res Commun284 2001 2 461 465 . - 163.
Roy S. Luetterforst R. Harding A. Apolloni A. Etheridge M. et al. Caveolae-Dependent Endocytosis in Viral Infection Nat Cell Biol1 1999 2 98 105 . - 164.
Gianni T. Gatta V. Campadelli-Fiume G. {alpha} Caveolae-Dependent Endocytosis in Viral Infection Proc Natl Acad Sci U S A107 10751 51 22260 22265 . - 165.
Lakadamyali M. MJ Rust Zhuang. X. Caveolae-Dependent Endocytosis in Viral Infection Microbes Infect6 2004 10 929 936 . - 166.
Shatz M. Lustig G. Reich R. Liscovitch M. Caveolin mutants P1. 132L 132 and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Exp Cell Res 2010;316(10) 1748-1762. - 167.
Conner SD, Schmid SL. Caveolae-Dependent Endocytosis in Viral Infection 422 2003 6927 37 44 . - 168.
Insel PA, Patel HH. Caveolae-Dependent Endocytosis in Viral Infection Br J Pharmacol150 2007 3 251 254 .